Sollinda Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,713
Closed -$215K 77
2025
Q4
$215K Hold
1,713
0.05% 71
2025
Q3
$229K Sell
1,713
-15,866
-90% -$2.08M 0.06% 65
2025
Q2
$2.39M Buy
17,579
+15,517
+753% +$2.05M 0.62% 20
2025
Q1
$274K Sell
2,062
-106
-5% -$13.5K 0.08% 55
2024
Q4
$245K Buy
2,168
+66
+3% +$7.63K 0.07% 63
2024
Q3
$240K Hold
2,102
0.07% 54
2024
Q2
$218K Buy
2,102
+73
+4% +$7.74K 0.07% 56
2024
Q1
$231K Hold
2,029
0.07% 51
2023
Q4
$223K Buy
+2,029
New +$203K 0.06% 79

Other funds holding ABT

Sollinda Capital Management's ABT Position: Q1 2026 in Review

Sollinda Capital Management sold out of Abbott (ABT) in Q1 2026, closing a stake of 1,713 shares — an estimated $215K sold.

Sollinda Capital Management first reported a position in ABT in Q4 2023 and held it in 9 quarters. The position peaked at $2.39M in Q2 2025. 3,106 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Sollinda Capital Management reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
  • Sollinda Capital Management sold 1,713 Abbott shares in Q1 2026, an estimated $215K.
  • Sollinda Capital Management first reported a position in Abbott in Q4 2023 and held it in 9 quarters.
  • Sollinda Capital Management's Abbott position peaked at $2.39M in Q2 2025.
  • 3,106 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Sollinda Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.